Computational Prediction of the Interaction of Ivermectin with Fibrinogen
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241411449 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Paola Vottero und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of Alberta, Edmonton, AB T6G 1Z2, Canada. Hauptthemen laut MEDLINE: COVID-19, Fibrinogen, Ivermectin, Thrombosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS.
Abstract (Originalsprache)
Hypercoagulability and formation of extensive and difficult-to-lyse microclots are a hallmark of both acute COVID-19 and long COVID. Fibrinogen, when converted to fibrin, is responsible for clot formation, but abnormal structural and mechanical clot properties can lead to pathologic thrombosis. Recent experimental evidence suggests that the spike protein (SP) from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may directly bind to the blood coagulation factor fibrinogen and induce structurally abnormal blood clots with heightened proinflammatory activity. Accordingly, in this study, we used molecular docking and molecular dynamics simulations to explore the potential activity of the antiparasitic drug ivermectin (IVM) to prevent the binding of the SARS-CoV-2 SP to fibrinogen and reduce the occurrence of microclots. Our computational results indicate that IVM may bind with high affinity to multiple sites on the fibrinogen peptide, with binding more likely in the central, E region, and in the coiled-coil region, as opposed to the globular D region. Taken together, our in silico results suggest that IVM may interfere with SP–fibrinogen binding and, potentially, decrease the formation of fibrin clots resistant to degradation. Additional in vitro studies are warranted to validate whether IVM binding to fibrinogen is sufficiently stable to prevent interaction with the SP, and potentially reduce its thrombo-inflammatory effect in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, University of Alberta, Edmonton, AB T6G 1Z2, Canada.
- Department of Mechanical Engineering, University of Alberta, Edmonton, AB T6G 1H9, Canada.
- Obstetrics, Gynecology & Reproductive Sciences, Yale School of Medicine, P.O. Box 208063, New Haven, CT 06520-8063, USA.
- US Public Health Service, Commissioned Corps, Inactive Reserve, Blacksburg, VA 24060-6367, USA.
- Department of Physics, University of Alberta, Edmonton, AB T6G 1Z2, Canada.
- DIMEAS, Politecnico di Torino, 10129 Turin, Italy.
ORCID-Profile: Alessandro D Santin, David E Scheim, Jack A Tuszynski
Förderung
- NCATS NIH HHS
Zitieren
APA
Vottero, P., Tavernini, S., Santin, A. D., Scheim, D. E., Tuszynski, J. A., & Aminpour, M. (2023). Computational Prediction of the Interaction of Ivermectin with Fibrinogen. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241411449
Vancouver
Vottero P, Tavernini S, Santin AD, Scheim DE, Tuszynski JA, Aminpour M. Computational Prediction of the Interaction of Ivermectin with Fibrinogen. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241411449
BibTeX
@article{Vottero2023,
author = {Vottero, Paola and Tavernini, Scott and Santin, Alessandro D and Scheim, David E and Tuszynski, Jack A and Aminpour, Maral},
title = {Computational Prediction of the Interaction of Ivermectin with Fibrinogen},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241411449}
}
EUVIMED